» Articles » PMID: 37895163

The Role of Vitamin D and Its Molecular Bases in Insulin Resistance, Diabetes, Metabolic Syndrome, and Cardiovascular Disease: State of the Art

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Oct 28
PMID 37895163
Authors
Affiliations
Soon will be listed here.
Abstract

In the last decade, an increasing awareness was directed to the role of Vitamin D in non-skeletal and preventive roles for chronic diseases. Vitamin D is an essential hormone in regulating calcium/phosphorous balance and in the pathogenesis of inflammation, insulin resistance, and obesity. The main forms of vitamin D, Cholecalciferol (Vitamin D3) and Ergocalciferol (Vitamin D2) are converted into the active form (1,25-dihydroxyvitamin D) thanks to two hydroxylations in the liver, kidney, pancreas, and immune cells. Some anti-inflammatory cytokines are produced at higher levels by vitamin D, while some pro-inflammatory cytokines are released at lower levels. Toll-Like Receptor (TLR) expression is increased, and a pro-inflammatory state is also linked to low levels of vitamin D. Regardless of how it affects inflammation, various pathways suggest that vitamin D directly improves insulin sensitivity and secretion. The level of vitamin D in the body may change the ratio of pro- to anti-inflammatory cytokines, which would impact insulin action, lipid metabolism, and the development and function of adipose tissue. Many studies have demonstrated an inverse relationship between vitamin D concentrations and pro-inflammatory markers, insulin resistance, glucose intolerance, metabolic syndrome, obesity, and cardiovascular disease. It is interesting to note that several long-term studies also revealed an inverse correlation between vitamin D levels and the occurrence of diabetes mellitus. Vitamin D supplementation in people has controversial effects. While some studies demonstrated improvements in insulin sensitivity, glucose, and lipid metabolism, others revealed no significant effect on glycemic homeostasis and inflammation. This review aims to provide insight into the molecular basis of the relationship between vitamin D, insulin resistance, metabolic syndrome, type 1 and 2 diabetes, gestational diabetes, and cardiovascular diseases.

Citing Articles

Multivitamin supplementation and its impact in metabolic dysfunction-associated steatotic liver disease.

Ryu T, Chae S, Lee J, Han J, Yang H, Chung B Sci Rep. 2025; 15(1):8675.

PMID: 40082562 PMC: 11906897. DOI: 10.1038/s41598-025-92858-0.


Vitamin D and Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Implications-A Narrative Review.

Fuentes-Barria H, Aguilera-Eguia R, Flores-Fernandez C, Angarita-Davila L, Rojas-Gomez D, Alarcon-Rivera M Int J Mol Sci. 2025; 26(5).

PMID: 40076782 PMC: 11900948. DOI: 10.3390/ijms26052153.


Evaluating the Role of Vitamin D in Prediabetes Management, Insights from RCTs in the MENA Region: A Comprehensive Systematic Review.

Al-Hetar M, Rusli N, Kamaruzzaman M, Al-Goshae H, Wan Ngah W, Shah S J Clin Med. 2025; 14(4).

PMID: 40004770 PMC: 11856371. DOI: 10.3390/jcm14041239.


Hypovitaminosis D in patients with oral leukoplakia: insights from a cross-sectional study.

Maturana-Ramirez A, Aitken-Saavedra J, Mora-Ferraro D, Rojas-Zuniga G, Espinoza-Santander I, Rojas-Alcayaga G Front Oncol. 2025; 15:1522726.

PMID: 39980554 PMC: 11839706. DOI: 10.3389/fonc.2025.1522726.


The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights.

Huang Z, Yao Q, Ma S, Zhou J, Wang X, Meng Q Front Microbiol. 2025; 16:1504395.

PMID: 39944642 PMC: 11814227. DOI: 10.3389/fmicb.2025.1504395.


References
1.
Kabadi S, Lee B, Liu L . Joint effects of obesity and vitamin D insufficiency on insulin resistance and type 2 diabetes: results from the NHANES 2001-2006. Diabetes Care. 2012; 35(10):2048-54. PMC: 3447853. DOI: 10.2337/dc12-0235. View

2.
Jahanjoo F, Farshbaf-Khalili A, Shakouri S, Dolatkhah N . Maternal and Neonatal Metabolic Outcomes of Vitamin D Supplementation in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. Ann Nutr Metab. 2018; 73(2):145-159. DOI: 10.1159/000491643. View

3.
Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm B . Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta. 2010; 411(17-18):1354-60. DOI: 10.1016/j.cca.2010.05.037. View

4.
Maged A, Torky H, Fouad M, GadAllah S, Waked N, Gayed A . Role of antioxidants in gestational diabetes mellitus and relation to fetal outcome: a randomized controlled trial. J Matern Fetal Neonatal Med. 2016; 29(24):4049-54. DOI: 10.3109/14767058.2016.1154526. View

5.
Cade C, Norman A . Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology. 1986; 119(1):84-90. DOI: 10.1210/endo-119-1-84. View